Published in J Nanomed Nanotechnol on October 01, 2015
Quantifying the Impact of Nanoparticle Coatings and Nonuniformities on XPS Analysis: Gold/Silver Core-Shell Nanoparticles. Anal Chem (2016) 0.95
Impact of pulmonary exposure to gold core silver nanoparticles of different size and capping agents on cardiovascular injury. Part Fibre Toxicol (2016) 0.78
Disposition of intravenously or orally administered silver nanoparticles in pregnant rats and the effect on the biochemical profile in urine. J Appl Toxicol (2016) 0.75
Provenance information as a tool for addressing engineered nanoparticle reproducibility challenges. Biointerphases (2016) 0.75
Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect (2005) 17.71
Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science (2013) 3.22
Regulation of the inflammatory response in cardiac repair. Circ Res (2012) 3.21
Effects of air pollution on the incidence of myocardial infarction. Heart (2009) 2.33
TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther (2010) 2.01
Use of coated silver nanoparticles to understand the relationship of particle dissolution and bioavailability to cell and lung toxicological potential. Small (2013) 1.62
Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Part Fibre Toxicol (2011) 1.52
C₆₀ exposure augments cardiac ischemia/reperfusion injury and coronary artery contraction in Sprague Dawley rats. Toxicol Sci (2014) 1.47
Pluronic F108 coating decreases the lung fibrosis potential of multiwall carbon nanotubes by reducing lysosomal injury. Nano Lett (2012) 1.40
Size dependent macrophage responses and toxicological effects of Ag nanoparticles. Chem Commun (Camb) (2011) 1.39
Silver enhancement of quantum dots resulting from (1) metabolism of toxic metals in animals and humans, (2) in vivo, in vitro and immersion created zinc-sulphur/zinc-selenium nanocrystals, (3) metal ions liberated from metal implants and particles. Prog Histochem Cytochem (2006) 1.29
Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles. Toxicol Lett (2012) 1.25
The distribution of dust in the rat lung following administration by inhalation and by single intratracheal instillation. Environ Res (1985) 1.23
Cardiovascular remodeling in response to long-term exposure to fine particulate matter air pollution. Circ Heart Fail (2012) 1.20
Shape matters: effects of silver nanospheres and wires on human alveolar epithelial cells. Part Fibre Toxicol (2011) 1.14
The stability of silver nanoparticles in a model of pulmonary surfactant. Environ Sci Technol (2013) 1.09
Cytokines and cardiovascular disease. J Leukoc Biol (2005) 1.08
p38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells. Environ Sci Technol (2010) 1.08
Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects. Appl Microbiol Biotechnol (2014) 1.08
Antimicrobial silver: uses, toxicity and potential for resistance. Biometals (2013) 1.06
Food storage material silver nanoparticles interfere with DNA replication fidelity and bind with DNA. Nanotechnology (2009) 1.03
A carbon nanotube toxicity paradigm driven by mast cells and the IL-₃₃/ST₂ axis. Small (2012) 1.02
Innate immunity and cardiomyocytes in ischemic heart disease. Life Sci (2014) 1.02
Expansion of cardiac ischemia/reperfusion injury after instillation of three forms of multi-walled carbon nanotubes. Part Fibre Toxicol (2012) 1.01
Environmental and human health risks of aerosolized silver nanoparticles. J Air Waste Manag Assoc (2010) 1.00
Molecular toxicity mechanism of nanosilver. J Food Drug Anal (2014) 1.00
Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors. Toxicol Sci (2014) 0.99
Cytotoxic and proinflammatory effects of PVP-coated silver nanoparticles after intratracheal instillation in rats. Beilstein J Nanotechnol (2013) 0.99
Comparison of 20 nm silver nanoparticles synthesized with and without a gold core: Structure, dissolution in cell culture media, and biological impact on macrophages. Biointerphases (2015) 0.93
Influence of particle size on persistence and clearance of aerosolized silver nanoparticles in the rat lung. Toxicol Sci (2015) 0.92
Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders. Heart Fail Clin (2009) 0.92
Global gene expression profiling of human lung epithelial cells after exposure to nanosilver. Toxicol Sci (2012) 0.91
Acute pulmonary toxicity and body distribution of inhaled metallic silver nanoparticles. Toxicol Res (2012) 0.90
Pulmonary instillation of multi-walled carbon nanotubes promotes coronary vasoconstriction and exacerbates injury in isolated hearts. Nanotoxicology (2012) 0.89
Pulmonary toxicity of instilled silver nanoparticles: influence of size, coating and rat strain. PLoS One (2015) 0.89
Influence of physicochemical properties of silver nanoparticles on mast cell activation and degranulation. Toxicol In Vitro (2015) 0.88
Pulmonary and cardiovascular responses of rats to inhalation of silver nanoparticles. J Toxicol Environ Health A (2013) 0.88
Vascular hypercontractility and endothelial dysfunction before development of atherosclerosis in moderate dyslipidemia: role for nitric oxide and interleukin-6. Am J Cardiovasc Dis (2014) 0.87
Pulmonary effects of silver nanoparticle size, coating, and dose over time upon intratracheal instillation. Toxicol Sci (2015) 0.86
PVP formulated fullerene (C60) increases Rho-kinase dependent vascular tissue contractility in pregnant Sprague Dawley rats. Reprod Toxicol (2014) 0.86
Development of silver nanoparticle loaded antibacterial polymer mesh using plasma polymerization process. J Biomed Mater Res A (2012) 0.82
The emerging role of outdoor and indoor air pollution in cardiovascular disease. N Am J Med Sci (2013) 0.81
Cardiac oxidative damage in mice following exposure to nanoparticulate titanium dioxide. J Biomed Mater Res A (2013) 0.80
Interleukin-1β blockade improves left ventricular systolic/diastolic function and restores contractility reserve in severe ischemic cardiomyopathy in the mouse. J Cardiovasc Pharmacol (2014) 0.79
Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells. J Transl Med (2014) 0.78
Ultrafine carbon particle mediated cardiovascular impairment of aged spontaneously hypertensive rats. Part Fibre Toxicol (2014) 0.78
A role for innate immunity in the development of hypertension. Med Hypotheses (2014) 0.77
Lung distribution, quantification, co-localization and speciation of silver nanoparticles after lung exposure in mice. Toxicol Lett (2015) 0.77